Cargando…
Thrombotic Complications after COVID-19 Vaccination: Diagnosis and Treatment Options
Coronavirus disease 2019 (COVID-19) vaccines were developed a few months after the emergence of the pandemic. The first cases of vaccine-induced thrombotic complications after the use of adenoviral vector vaccines ChAdOx1 nCoV-19 by AstraZeneca, and Ad26.COV2.S by Johnson & Johnson/Janssen, were...
Autores principales: | Guetl, Katharina, Raggam, Reinhard Bernd, Gary, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220036/ https://www.ncbi.nlm.nih.gov/pubmed/35740269 http://dx.doi.org/10.3390/biomedicines10061246 |
Ejemplares similares
-
SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban
por: Guetl, Katharina, et al.
Publicado: (2021) -
Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination
por: Gattringer, Thomas, et al.
Publicado: (2021) -
The White Blood Cell Count to Mean Platelet Volume Ratio for the Prediction of Chronic Limb-Threatening Ischemia in Lower Extremity Artery Disease
por: Guetl, Katharina, et al.
Publicado: (2019) -
Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment
por: Gąsecka, Aleksandra, et al.
Publicado: (2020) -
Thrombotic complications of COVID-19
por: Avila, Jacob, et al.
Publicado: (2021)